Thompson Siegel & Walmsley LLC Bio Rad Laboratories, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.71 Billion
- Q3 2024
A detailed history of Thompson Siegel & Walmsley LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 306,793 shares of BIO stock, worth $104 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
306,793
Previous 390,020
21.34%
Holding current value
$104 Million
Previous $107 Million
3.63%
% of portfolio
1.53%
Previous 1.71%
Shares
14 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$646 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$525 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$442 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$368 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$242 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.35B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...